The review discusses the relationship between acromegaly and uterine fibroids. It highlights variations in research methodologies and inconsistent findings, emphasizing the complex nature of fibroid development and the role of the somatotropic axis. Additionally, it addresses demographic factors and examines the potential impact of therapies on the risk and prevalence of uterine fibroids in individuals with acromegaly. We conducted an analysis of previously published literature that examined the repercussions of acromegaly on gynecological health in female cohorts, with specific attention directed towards elucidating the prevalence of uterine fibroids. We suggest that larger, more focused studies are needed to understand the specific impact of different treatments on the occurrence of gynecological issues in acromegaly patients. Additionally, our study emphasizes the importance of factors such as disease duration and treatment effectiveness. We hypothesize that a relationship between acromegaly and uterine fibroids may occur. However, it remains an area of ongoing research, with the need for larger, multi-center studies to draw more definitive conclusions.
Keyphrases
- pregnancy outcomes
- growth hormone
- systematic review
- end stage renal disease
- healthcare
- randomized controlled trial
- public health
- newly diagnosed
- ejection fraction
- pregnant women
- chronic kidney disease
- risk assessment
- metabolic syndrome
- type diabetes
- patient reported outcomes
- squamous cell carcinoma
- working memory
- peritoneal dialysis
- adipose tissue
- cervical cancer screening